Trial Profile
Phase II Study of Prophylactic Anticoagulation for Preventing Deep Vein Thrombosis After Total Hip Arthroplasty.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 17 Oct 2011
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Deep vein thrombosis
- Focus Therapeutic Use
- Acronyms NJDVTS
- 07 Oct 2011 New trial record